Drug Toxicity
47
3
4
23
Key Insights
Highlights
Success Rate
88% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
6.4%
3 terminated out of 47 trials
88.5%
+2.0% vs benchmark
15%
7 trials in Phase 3/4
26%
6 of 23 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 23 completed trials
Clinical Trials (47)
TDM for Optimized Outcome in Patients With mRCC.
Real World Asparaginase Therapy Toxicity
Infliximab for Treatment of Immune Checkpoint Inhibitor Colitis
Pharmacogenomic Association Study in Indian Children With Acute Lymphoblastic Leukemia
Effect of Tacrolimus Formulation on Neurological Side Effects in Older Kidney Transplant Recipients
Optimizing Vancomycin Therapy in Children
GHB Poisoning and Poisoning Induced by Others
Atrial Fibrillation in Active Cancer Patients
Double-Blind Randomized Crossover Trial to Access Electrocardiogram Effects of HPN-100
Reduction of MTX Levels After Glucarpidase Treatment in DLBCL Patients at Risk of CNS
Retrospective Registry Study of Patients With Cancer Treated With High-dose Methotrexate
Protective Effect of Nicotinamide Riboside Against Acetaminophen Toxicity
The Influence of Tramadol on Platelet Function
Role of N-Acetylcysteine for Prevention of Cisplatin-induced Nephrotoxicity
Safety and Efficacy of Expanded Allogeneic AD-MSCs in Patients With Moderate to Severe Psoriasis
Efficacy and Safety of AD-MSCs Plus Calpocitriol Ointment and PSORI-CM01 Granule in Psoriasis Patients
Efficacy and Safety of AD-MSCs Plus Calpocitriol Ointment in Patients With Moderate to Severe Psoriasis
A Big Data Approach to Predict NEOnatal Acute Kidney Injury in Newborns expoSed to nephroTOxic Drugs (NeoAKI STOP)
Monitoring the Antiphospholipid Syndrome:TOXicity of Drugs (APSTOX)
Monitoring the Hyperammonaemia:TOXicity of Drugs (AmmoTOX)